Understanding Schistosomiasis Treatment in Hard-to-Reach Areas of Kenya
Author Information
Author(s): Isaiah Phyllis Munyiva, Afriyie Doris Osei, Maghanga Mary, Ogeto Donna Obare, Nyamongo Mary Amuyunzu, Steinmann Peter
Primary Institution: Swiss Tropical and Public Health Institute
Hypothesis
What contextual factors influence schistosomiasis treatment and how can arpraziquantel be effectively delivered in hard-to-reach populations?
Conclusion
The door-to-door approach using community health promoters is the most effective way to deliver arpraziquantel to at-risk preschool-aged children in hard-to-reach areas.
Supporting Evidence
- Community members showed awareness of schistosomiasis but had limited knowledge of transmission risks.
- Barriers to healthcare access included poor infrastructure and financial constraints.
- Participants expressed willingness to participate in future mass drug administration programs.
- Door-to-door delivery by community health promoters was preferred for distributing arpraziquantel.
Takeaway
This study found that people in hard-to-reach areas of Kenya know about schistosomiasis but need better access to treatment, and delivering medicine directly to their homes is the best way to help them.
Methodology
A qualitative study using interviews, focus groups, and observations to understand treatment-related factors and delivery platforms for arpraziquantel.
Limitations
Findings may not be generalizable beyond the specific hard-to-reach areas studied due to the convenience sampling method.
Participant Demographics
Participants included parents and caregivers of children under 5 years, with a mix of genders and educational backgrounds, primarily from fishing communities.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website